These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38529202)

  • 1. A Meta-Analysis of MiRNA-497 and Prognosis of Hepatocellular Carcinoma.
    Xie Z; Hao Q; Zhu R; Ma R
    Can J Gastroenterol Hepatol; 2024; 2024():2211179. PubMed ID: 38529202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the value of miR-21 in the diagnosis of early stage HCC and its prognosis: a meta-analysis.
    Yan SR; Liu ZJ; Yu S; Bao YX
    Genet Mol Res; 2015 Sep; 14(3):11573-86. PubMed ID: 26436398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating miRNA-199a and miRNA-122 Levels as Potential Diagnostic and Prognostic Biomarkers for Hepatocellular Carcinoma.
    Wu J; Wu Y; Luo Y; Li X; Lin N; Yang X; Lin Y; Chen M
    Ann Clin Lab Sci; 2020 Mar; 50(2):219-227. PubMed ID: 32366560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical significance of microRNA-122 in predicting the prognosis of patients with hepatocellular carcinoma: A meta-analysis validated by the Cancer Genome Atlas dataset.
    Zhang Y; Li Y; Jiang W; Li Q; Lan Y
    Medicine (Baltimore); 2019 Mar; 98(13):e14810. PubMed ID: 30921182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of microRNA-130b correlates with poor prognosis of patients with hepatocellular carcinoma.
    Wang WY; Zhang HF; Wang L; Ma YP; Gao F; Zhang SJ; Wang LC
    Diagn Pathol; 2014 Aug; 9():160. PubMed ID: 25123453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prognostic Significance of miR-21 Expression among Surgically Resected Hepatocellular Carcinoma Patients: Evidence from a Meta-Analysis and Retrospective Cohort Study.
    Huang X; Xiong Y; Yang J; Yang G; Li J
    Biomed Res Int; 2020; 2020():8848158. PubMed ID: 33415165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-221 suppression through nanoparticle-based miRNA delivery system for hepatocellular carcinoma therapy and its diagnosis as a potential biomarker.
    Li F; Wang F; Zhu C; Wei Q; Zhang T; Zhou YL
    Int J Nanomedicine; 2018; 13():2295-2307. PubMed ID: 29713162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High serum microRNA-122 level is independently associated with higher overall survival rate in hepatocellular carcinoma patients.
    Xu Y; Bu X; Dai C; Shang C
    Tumour Biol; 2015 Jun; 36(6):4773-6. PubMed ID: 25636448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
    Chen L; Chu F; Cao Y; Shao J; Wang F
    Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of miR-3607 predicts prognosis of hepatocellular carcinoma and regulates tumor cell proliferation, migration and invasion.
    Dou W; Yang M; Su Y; Xie R
    Diagn Pathol; 2020 May; 15(1):54. PubMed ID: 32404179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
    Yang L; Xu Q; Xie H; Gu G; Jiang J
    Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significantly different expression levels of microRNAs associated with vascular invasion in hepatocellular carcinoma and their prognostic significance after surgical resection.
    Song SK; Jung WY; Park SK; Chung CW; Park Y
    PLoS One; 2019; 14(9):e0216847. PubMed ID: 31513595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma.
    Li BK; Huang PZ; Qiu JL; Liao YD; Hong J; Yuan YF
    Diagn Pathol; 2014 Dec; 9():226. PubMed ID: 25466449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of MicroRNA-937 Predicts a Poor Prognosis and Promotes Hepatocellular Carcinoma Cell Proliferation, Migration, and Invasion.
    Chen Z; Zhang Y
    Mol Biotechnol; 2022 Jan; 64(1):33-41. PubMed ID: 34519997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.
    Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T
    Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
    Cai L; Cai X
    Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of MicroRNA-497 in Various Cancers: A Systematic Review and Meta-Analysis.
    Liu Z; Wu S; Wang L; Kang S; Zhao B; He F; Liu X; Zeng Y; Liu J
    Dis Markers; 2019; 2019():2491291. PubMed ID: 31191744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-224 is an early-stage biomarker of hepatocellular carcinoma with miR-224 and miR-125b as prognostic biomarkers.
    Yang L; Wei C; Li Y; He X; He M
    Biomark Med; 2020 Oct; 14(15):1485-1500. PubMed ID: 33155836
    [No Abstract]   [Full Text] [Related]  

  • 20. Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma.
    Chen P; Zhao X; Ma L
    Mol Cell Biochem; 2013 Nov; 383(1-2):49-58. PubMed ID: 23842624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.